FDA approves AstraZeneca’s Calquence for untreated mantle cell lymphoma By Investing.com Stocks January 17, 2025 Investing.com — AstraZeneca (LON:) in a stock exchange filing on Friday said that the FDA approved its drug Calquence (acalabrutinib)…